These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5305238)

  • 1. Brain tumor chemotherapy with intrathecal methotrexate.
    Wilson CB; Norrell HA
    Cancer; 1969 May; 23(5):1038-45. PubMed ID: 5305238
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain tumor chemotherapy with methotrexate given intrathecally. A new technique.
    Norrell H; Wilson C
    JAMA; 1967 Jul; 201(1):93-5. PubMed ID: 6071702
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study.
    van Eys J; Chen T; Moore T; Cheek W; Sexauer C; Starling K
    Cancer Treat Rep; 1981; 65(7-8):681-4. PubMed ID: 7248985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors].
    Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal cytostatic chemotherapy of meningitis carcinomatosa. Clinical manifestation and cerebrospinal fluid cytology in a case of metastatic carcinoma of the breast.
    Dommasch D; Przuntek H; Grüninger W; Mertens HG
    Eur Neurol; 1976; 14(3):178-91. PubMed ID: 179823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy.
    Tator CH; Wassenaar W
    J Neurosurg; 1977 Feb; 46(2):165-74. PubMed ID: 833633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with intrathecal administration of methotrexate in the chemotherapy of malignant intracerebral tumors].
    Romodanov AP; Sosnov IuD; Shcheglov VI
    Vopr Neirokhir; 1975; (1):32-5. PubMed ID: 164086
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukaemic meningo-encephalopathy: treatment with intrathecal methotrexate.
    Misra RC; Basu AK
    J Assoc Physicians India; 1973 Oct; 21(10):895-903. PubMed ID: 4802076
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.
    Norrell H; Wilson CB; Slagel DE; Clark DB
    Cancer; 1974 Apr; 33(4):923-32. PubMed ID: 4819222
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal methotrexate overdose without neurotoxicity: case report and literature review.
    Ettinger LJ; Freeman AI; Creaven PJ
    Cancer; 1978 Apr; 41(4):1270-3. PubMed ID: 346194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration.
    Ushio Y; Hayakawa T; Mogami H
    J Neurosurg; 1974 Jun; 40(6):706-16. PubMed ID: 4406460
    [No Abstract]   [Full Text] [Related]  

  • 12. Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia.
    Sullivan MP; Humphrey GB; Vietti TJ; Haggard ME; Lee E
    Cancer; 1975 Apr; 35(4):1066-73. PubMed ID: 803866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate permeability and steady-state distribution in the murine ependymoblastoma.
    Levin VA; Clancy TP; Ausman JI
    Trans Am Neurol Assoc; 1969; 94():294-6. PubMed ID: 5374467
    [No Abstract]   [Full Text] [Related]  

  • 14. Submicroscopic changes in leukaemia cells of the cerebrospinal fluid following intrathecal methotrexate.
    Péter A
    Acta Neuropathol; 1974; 29(4):345-54. PubMed ID: 4531812
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytological changes in the cerebrospinal fluid following intrathecal methotrexate treatment. I. Observations in adult meningeal leukemia.
    Péter A
    Confin Neurol; 1974; 36(3):186-96. PubMed ID: 4533245
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of primary brain tumors.
    Levin VA
    Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal methotrexate therapy of brain tumors of childhood.
    Sayers MP
    Ohio State Med J; 1969 Apr; 65(4):383-5. PubMed ID: 5819618
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrathecal methotrexate (NSC-740) therapy for brain tumors in children.
    Newton WA; Sayers MP; Samuels LD
    Cancer Chemother Rep; 1968 Feb; 52(2):257-61. PubMed ID: 5694473
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal injection of methotrexate (NSC-740) in transplanted brain tumors.
    Wilson CB; Norrell H; Barker M
    Cancer Chemother Rep; 1967 Feb; 51(1):1-6. PubMed ID: 6072045
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.